Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Bkm120

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Phase 1 (1)
Phase 2 (2)

Trial Status

Recruiting1
Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07887971Phase 1Recruiting

A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors

NCT01449201Phase 2CompletedPrimary

PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma

NCT01527877Phase 2UnknownPrimary

Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck

Showing all 3 trials

Research Network

Common Treatments

  • Bkm1201
  • Pf002998041
  • 64cucuaky2519 Imaging1
  • 225acacaky2519 Therapeutic1

Active Sponsors

  • Yonsei University2
  • Aktis Oncology, Inc.1

Top Investigators

Related Conditions

  • Head Neck Cancer Squamous Cell Recurrent2
  • Prostate Cancer1
  • Essclc1
  • Nsclc1
  • Hnscc1

Activity Timeline